Clinical Trials Directory

Trials / Completed

CompletedNCT01835860

Prostatic Artery Embolization for Benign Prostatic Hyperplasia

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
13 (actual)
Sponsor
Saskatchewan Health Authority - Regina Area · Academic / Other
Sex
Male
Age
Healthy volunteers
Not accepted

Summary

To evaluate whether Prostatic Artery Embolization (PAE) might be an effective alternative treatment option for benign prostatic hyperplasia (BPH), in comparison to current gold standard surgical treatment- Transurethral Resection of Prostate (TURP).

Conditions

Interventions

TypeNameDescription
PROCEDUREProstate artery embolization

Timeline

Start date
2013-03-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2013-04-19
Last updated
2016-04-07

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01835860. Inclusion in this directory is not an endorsement.

Prostatic Artery Embolization for Benign Prostatic Hyperplasia (NCT01835860) · Clinical Trials Directory